Mild Cognitive Impairment (MCI) clinical trials
Showing 151–200 of 228 active trials. Describe your situation to see which ones look like a fit.
- Cognition, Flavonoids, Exercise, Gut Microbiome
- Group Recreation to Enhance Function Aging
- Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers
- Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
- A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
- FACE Phase II (a Stage II Trial)
- Paper-Based and Smartphone-Based Memory Supports
- Indian Transforming Alzheimer's Care Training (INTACT)
- Biomarker Exploration in Aging, Cognition and Neurodegeneration
- Music for Pain and Dementia
- Clinical Applications of Advanced Ophthalmic Imaging
- Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
- The Gut - PRO Study
- Epileptic Hippocampus in Alzheimer's Disease
- Ketogenic Diet to Reduce Osteoarthritis Pain in MCI
- Cognitive-Motor Training for AD/ADRD Prevention
- iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS
- Cognitive Integrated Motor Training (CM) to Improve Gait and Balance and Reduce Falls in Older Adults With Mild Cognitive Impairment
- Personalized Closed-Loop Brain Stimulation for Patients With Mild Cognitive Impairment
- Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2
- Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1
- 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
- SleepSMART for Veterans With Insomnia and Mild Cognitive Impairment
- Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.
- Light and Sleep Fragmentation
- Percepta for Cognitive Optimization
- RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β
- An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
- AI-CONECT: A Conversational AI for Early Dementia Prevention in Socially-Isolated Older Adults
- Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment
- Implementation of AIP Services for Older Adults With AD
- Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog
- Navigating the Clinical Research Process for Mild Cognitive Impairment
- Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer s Disease
- Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
- Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease
- Ultrasonic Debris Clearance to Promote Brain Resilience
- Fall Prevention in Mild Cognitive Impairment
- Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment
- Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
- Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
- Mild Cognitive Impairment and Neuromodulation
- Learning Amyloid and Tau Results
- Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
- Assessing and Improving the Durability of Compensatory Cognitive Training for Older Veterans
- The Comparative Effectiveness Dementia & Alzheimer's Registry
- Application of the Modified Story Memory Technique (mSMT)© to Aging
- Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease
- Expanding Access to Cognitive Health Biomarker Testing at Home
- AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.